New injection shows promise against tough cancers
Disease control
Recruiting now
This study tests an experimental drug called N17350 in adults with advanced solid tumors that have not responded to standard treatments. The drug is injected directly into tumors every two weeks for up to 12 weeks. Researchers aim to find the safest and most effective dose, and s…
Phase: PHASE1, PHASE2 • Sponsor: Onchilles Pharma Inc • Aim: Disease control
Last updated May 15, 2026 11:53 UTC